Parrondo, R. D., de Menezes, R., Sledge, H., Nayyar, M., Yadav, K., Bergsagel, L., Fonseca, R., Kapoor, P., Buadi, F., Gertz, M. A., Dispenzieri, A., Roy, V., Sher, T., Binder, M., Abdallah, N., Chhabra, S., Rajkumar, V. S., Gonsalves, W. I., Cook, J., Dingli, D., Lin, Y., Fernandez, A., Flott, C., Yadav, U., Warsame, R. M., Wiedmeier-Nutor, E. E., Kourelis, T., Leung, N., Siddiqui, M. A., Kumar, S., Chanan-Khan, A. A. and Ailawadhi, S. (2020) “Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.300401.